Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-18 5:05 pm Purchase | 2026-06-11 | 13G | EDESA BIOTECH INC EDSA | Integrated Core Strategies (US) LLC | 520,685 5.400% | 520,685 (New Position) | Filing History |
| 2026-06-16 5:06 pm Purchase | 2026-06-16 | 13D | EDESA BIOTECH INC EDSA | Nijhawan Pardeep | 2,210,022 19.990% | 169,237 (+8.29%) | Filing History |
| 2026-05-15 5:15 pm Sale | 2026-03-31 | 13G | EDESA BIOTECH INC EDSA | Stonepine Capital Management, LLC | 30,000 0.300% | -663,551 (-95.67%) | Filing History |
| 2026-05-15 4:42 pm Sale | 2026-03-31 | 13G | EDESA BIOTECH INC EDSA | Nantahala Capital Management, LLC | 0 0.000% | -855,583 (Position Closed) | Filing History |
| 2026-05-15 4:27 pm Sale | 2026-03-31 | 13G | EDESA BIOTECH INC EDSA | Point72 Asset Management, L.P. | 2 0.000% | -599,998 (-100.00%) | Filing History |
| 2026-05-15 4:03 pm Purchase | 2025-03-31 | 13G | EDESA BIOTECH INC EDSA | Rubric Capital Management LP | 687,500 7.740% | 687,500 (New Position) | Filing History |
| 2026-05-15 08:14 am Purchase | 2026-03-31 | 13G | EDESA BIOTECH INC EDSA | Sirenia Capital Management LP | 600,000 7.200% | 600,000 (New Position) | Filing History |
| 2026-03-16 4:00 pm Purchase | 2026-03-09 | 13G | EDESA BIOTECH INC EDSA | Perceptive Advisors LLC | 563,239 6.700% | 563,239 (New Position) | Filing History |
| 2026-03-03 4:25 pm Purchase | 2026-02-24 | 13G | EDESA BIOTECH INC EDSA | Point72 Asset Management, L.P. | 600,000 7.200% | 600,000 (New Position) | Filing History |
| 2026-03-02 7:03 pm Purchase | 2026-02-26 | 13D | EDESA BIOTECH INC EDSA | Velan Capital Master Fund LP | 834,700 9.990% | 141,149 (+20.35%) | Filing History |
| 2026-03-02 5:11 pm Purchase | 2026-02-26 | 13D | EDESA BIOTECH INC EDSA | Nijhawan Pardeep | 2,040,785 19.990% | 444,204 (+27.82%) | Filing History |
| 2026-02-13 5:05 pm Purchase | 2025-12-31 | 13G | EDESA BIOTECH INC EDSA | Nantahala Capital Management, LLC | 855,583 9.990% | 155,095 (+22.14%) | Filing History |
| 2025-05-15 4:46 pm Purchase | 2025-03-31 | 13G | EDESA BIOTECH INC EDSA | Nantahala Capital Management, LLC | 700,488 9.990% | 700,488 (New Position) | Filing History |
| 2025-02-25 5:16 pm Purchase | 2025-02-13 | 13G | EDESA BIOTECH INC EDSA | Stonepine Capital Management, LLC | 693,551 9.900% | 693,551 (New Position) | Filing History |
| 2025-02-18 5:48 pm Purchase | 2025-02-12 | 13D | EDESA BIOTECH INC EDSA | Velan Capital Master Fund LP | 693,551 9.990% | 630,059 (+992.34%) | Filing History |
| 2025-02-18 4:15 pm Sale | 2025-02-13 | 13G | EDESA BIOTECH INC EDSA | Thomas A. Satterfield, Jr. | 0 0.000% | -232,161 (Position Closed) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2025-02-12 | 13D | EDESA BIOTECH INC EDSA | Nijhawan Pardeep | 1,596,581 19.990% | 921,257 (+136.42%) | Filing History |
| 2025-02-12 08:00 am Purchase | 2024-12-31 | 13G | EDESA BIOTECH INC EDSA | Thomas A. Satterfield, Jr. | 232,161 6.700% | 56,117 (+31.88%) | Filing History |
| 2024-11-01 8:50 pm Purchase | 2024-10-30 | 13D | EDESA BIOTECH INC EDSA | Nijhawan Pardeep | 675,324 19.990% | 265,585 (+64.82%) | Filing History |
| 2024-06-03 4:10 pm Purchase | 2024-05-30 | 13G | EDESA BIOTECH INC EDSA | Thomas A. Satterfield, Jr. | 176,044 5.470% | 176,044 (New Position) | Filing History |